» Articles » PMID: 36836743

A Scoping Review of Sleep Apnea: Where Do We Stand?

Overview
Journal Life (Basel)
Specialty Biology
Date 2023 Feb 25
PMID 36836743
Authors
Affiliations
Soon will be listed here.
Abstract

Obstructive sleep apnea (OSA), a condition in which there is a recurrent collapse of the upper airway while sleeping, is a widespread disease affecting 5% to 10% people worldwide. Despite several advances in the treatment modalities for OSA, morbidity and mortality remain a concern. Common symptoms include loud snoring, gasping for air during sleep, morning headache, insomnia, hypersomnia, attention deficits, and irritability. Obese individuals, male gender, older age (65+), family history, smoking, and alcohol consumption are well recognized risk factors of OSA. This condition holds the ability to increase inflammatory cytokines, cause metabolic dysfunction, and increase the sympathetic output, all of which exacerbate OSA due to their effect on the cardiovascular system. In this review, we discuss its brief history, risk factors, complications, treatment modalities, and the role of clinicians in curbing its risk.

Citing Articles

Sleep Apnea Detection Using EEG: A Systematic Review of Datasets, Methods, Challenges, and Future Directions.

Fathima S, Ahmed M Ann Biomed Eng. 2025; .

PMID: 39939549 DOI: 10.1007/s10439-025-03691-5.


Microglia and Sleep Disorders.

Picard K, Dolhan K, Watters J, Tremblay M Adv Neurobiol. 2024; 37:357-377.

PMID: 39207702 DOI: 10.1007/978-3-031-55529-9_20.


The Effects of Obstructive Sleep Apnea on the Cardiovascular System: A Comprehensive Review.

DiCaro M, Lei K, Yee B, Tak T J Clin Med. 2024; 13(11).

PMID: 38892933 PMC: 11172971. DOI: 10.3390/jcm13113223.


Symptom and comorbidity burden in hypertensive patients with obstructive sleep apnea.

Tao M, Dong X, Tu J, Fang Q, Shao C Front Endocrinol (Lausanne). 2024; 15:1361466.

PMID: 38501097 PMC: 10944929. DOI: 10.3389/fendo.2024.1361466.

References
1.
Bratel T, Wennlund A, Carlstrom K . Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). Respir Med. 1999; 93(1):1-7. DOI: 10.1016/s0954-6111(99)90068-9. View

2.
Eckert D, Malhotra A, Wellman A, White D . Trazodone increases the respiratory arousal threshold in patients with obstructive sleep apnea and a low arousal threshold. Sleep. 2014; 37(4):811-9. PMC: 4044741. DOI: 10.5665/sleep.3596. View

3.
Chang E, Fernandez-Salvador C, Giambo J, Nesbitt B, Liu S, Capasso R . Tongue retaining devices for obstructive sleep apnea: A systematic review and meta-analysis. Am J Otolaryngol. 2017; 38(3):272-278. DOI: 10.1016/j.amjoto.2017.01.006. View

4.
Saglam-Aydinatay B, Taner T . Oral appliance therapy in obstructive sleep apnea: Long-term adherence and patients experiences. Med Oral Patol Oral Cir Bucal. 2017; 23(1):e72-e77. PMC: 5822544. DOI: 10.4317/medoral.22158. View

5.
Friedman M, Ibrahim H, Bass L . Clinical staging for sleep-disordered breathing. Otolaryngol Head Neck Surg. 2002; 127(1):13-21. DOI: 10.1067/mhn.2002.126477. View